ALFA FinderNSE filing, NSE: AKUMS. Summary written from the filing by ALFA Finder's alert engine.
Akums Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹734.95
- Market cap
- ₹11,568 Cr
- Revenue (annual)
- ₹4,359 Cr
- Net profit (annual)
- ₹255.2 Cr
- P/E (TTM)
- 31.8×Sector 43.0×
- Promoter holding
- 75.26%+0.00% QoQ
- FII holding
- 4.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akums Drugs & Pharmaceuticals Ltd
All →Akums Drugs & Pharmaceuticals Earnings Call Transcript: Key Takeaways
Consolidated revenue ₹1,342 Cr (+31.9% YoY) and EBITDA ₹195 Cr (+106%), led by CDMO volumes. Management gave no numeric guidance. API still loss-making and domestic branded growth is only about 8%.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Limited has fully utilized its IPO proceeds totaling Rs. 680 Crore as of September 30, 2026. Consequently, further monitoring agency reports are no longer required.
- Value
- ₹680.0 Cr
Akums Drugs & Pharmaceuticals Investor Presentation: Key Takeaways
Q2 FY27: revenue INR 1,342 cr (+31.9% YoY), EBITDA INR 195 cr (14.5% margin), PAT INR 115 cr (+168.3% YoY). CDMO-led growth; API losses narrowing.
Akums Drugs & Pharmaceuticals Results Update
Akums reported Q2 FY27 revenue of ₹1,342 crore, up 31.9%, and PAT of ₹115 crore, up 168%. The release is a press update with highlights, not the full results statement.
Akums Drugs & Pharmaceuticals Q2 FY27 Results: Net Profit ₹114.6 Cr, Up 168.4% YoY
Akums Drugs & Pharmaceuticals Ltd reported revenue from operations of ₹1,342 Cr (+31.9% YoY) and net profit of ₹114.6 Cr (+168.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹114.6 Cr · +168.4% YoY
Akums Drugs & Pharmaceuticals Management Change
Akums Drugs announced the resignation of Mr. Sunil Jaiswal, SVP R&D and Senior Management Personnel, effective 31 October 2026. The resignation was submitted on 5 August 2026 citing family commitments.
Other financial results announcements
All →Velox Shipping and Logistics Q2 FY27 Results: Net Profit ₹0.8 Cr, Up 166.7% YoY
Velox Shipping and Logistics Ltd reported revenue from operations of ₹2.5 Cr and net profit of ₹0.8 Cr (+166.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.8 Cr · +166.7% YoY
Ecofinity Atomix Q2 FY27 Results: Net Profit ₹0.7 Cr, Up 16.7% YoY
Ecofinity Atomix Ltd reported revenue from operations of ₹26.5 Cr (+145.4% YoY) and net profit of ₹0.7 Cr (+16.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.7 Cr · +16.7% YoY
Transglobe Foods Q2 FY27 Results: Net Profit ₹0 Cr
Transglobe Foods reported unaudited Q2 and H1 FY27 results for the period ended 30 September 2026. The half-year net loss was ₹3.49 lakhs, with going-concern doubts noted.
- Key figure
- Net profit ₹0 Cr
Euro India Fresh Foods Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Euro India Fresh Foods Ltd reported revenue from operations of ₹29.9 Cr (-8.0% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Market Creators Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Market Creators Ltd reported revenue from operations of ₹1.4 Cr (+16.7% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Sharma East India Hospitals & Medical Research Q2 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY
Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.4 Cr (+10.6% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.3 Cr · +0.0% YoY